Technical Analysis for AVO - Advanced Oncotherapy Plc

Grade Last Price % Change Price Change
F 9.75 0.00% 0.00
AVO closed unchanged on Friday, February 3, 2023, on 81 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -2.50%
Wide Bands Range Expansion -2.50%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% 17 days ago
Possible Inside Day 17 days ago
2x Volume Pace 17 days ago
1.5x Volume Pace 17 days ago
Up 5% 17 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Advanced Oncotherapy Plc Description

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system uses accelerators, which is a series of modular units. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva, Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, the United States.


Sector: Healthcare
Industry: Medical Devices
Keywords: Health Healthcare Manufacturing Physical Sciences Natural Sciences Clinic Hospital Cancer Radio Therapy Clinical Research Medical Physics Adam Manufacturing Plant Radiotherapy Proton Cern Physics Radiation Therapy

Is AVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 32.0
52 Week Low 9.5
Average Volume 617,501
200-Day Moving Average 19.92
50-Day Moving Average 13.65
20-Day Moving Average 11.15
10-Day Moving Average 10.23
Average True Range 0.74
RSI 16.67
ADX 45.68
+DI 10.41
-DI 26.39
Chandelier Exit (Long, 3 ATRs) 11.76
Chandelier Exit (Short, 3 ATRs) 11.73
Upper Bollinger Bands 13.51
Lower Bollinger Band 8.79
Percent B (%b) 0.2
BandWidth 42.39
MACD Line -1.14
MACD Signal Line -1.17
MACD Histogram 0.0351
Fundamentals Value
Market Cap 32.51 Million
Num Shares 333 Million
EPS -14.00
Price-to-Earnings (P/E) Ratio -0.70
Price-to-Sales 0.00
Price-to-Book 2.02
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.50
Resistance 3 (R3) 10.50 10.25 10.38
Resistance 2 (R2) 10.25 10.06 10.25 10.33
Resistance 1 (R1) 10.00 9.94 10.00 10.00 10.29
Pivot Point 9.75 9.75 9.75 9.75 9.75
Support 1 (S1) 9.50 9.56 9.50 9.50 9.21
Support 2 (S2) 9.25 9.44 9.25 9.17
Support 3 (S3) 9.00 9.25 9.13
Support 4 (S4) 9.00